Related Experiment Video
Updated: Jul 13, 2026
08:47
Induction of Experimental Autoimmune Encephalomyelitis in Mice and Evaluation of the Disease-dependent Distribution of Immune Cells in Various Tissues
Published on: May 8, 2016
FcRL3 and multiple sclerosis pathogenesis: role in autoimmunity?
Alfonso Martínez1, Ana Mas, Virginia de Las Heras
1Department of Immunology, Hospital Clinico San Carlos, Madrid, Spain.
Journal of Neuroimmunology
|July 10, 2007
Summary
The FcRL3 gene's -169 T/C polymorphism increases susceptibility to multiple sclerosis (MS). This finding supports FcRL3's role in autoimmunity and MS pathogenesis.
Area of Science:
- Immunogenetics
- Autoimmune Disease Research
Background:
- The FcRL3 gene contains a functional promoter polymorphism (-169 T/C) known to influence gene expression.
- This polymorphism has been implicated in the pathogenesis of various autoimmune diseases.
Purpose of the Study:
- To investigate for the first time the potential involvement of the FcRL3 gene in the development of multiple sclerosis (MS).
Main Methods:
- A case-control study was conducted with 400 Spanish MS patients and 508 healthy controls.
- Genotyping for the FcRL3 -169 T/C and -110 G/A polymorphisms was performed using TaqMan MGB chemistry.
Main Results:
- A significant difference in FcRL3 -169 T/C genotype distribution was observed between MS patients and controls (p = 0.03).
- The -169 T allele showed a parallel effect in MS, increasing susceptibility (p = 0.013; OR = 1.55).
Conclusions:
- The -169 T allele of FcRL3 is associated with increased susceptibility to multiple sclerosis.
- This finding supports the FcRL3 locus's role in MS predisposition and its broader influence on autoimmune conditions.
Related Concept Videos
01:19Multiple Sclerosis l: Introduction
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
01:24T Cell Types and Functions
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
01:25Inflammatory Bowel Disease III: Crohn's Disease
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
01:29Autoimmune Disorders
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune system...
Concept and Mechanism of Autoimmune Diseases
The immune system...
01:22Myasthenia Gravis ll: Pathophysiology
The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
01:23Cystic Fibrosis: Pathogenesis
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...